
Publication
Blue Bonds: Making a splash in the Capital Markets
In 2018, the Republic of Seychelles launched the first-ever “blue bond”, with the support of the World Bank Group and the Global Environment Facility.
Authors:
Global | Publication | August 2024
The rapid convergence of digital technologies with healthcare over the past five years (even prior to the COVID-19 pandemic) has transformed how healthcare is delivered to the masses. The promise of digital technologies continues to transform the healthcare delivery model from a traditional model based on a “one-size-fits-all” practice of medicine that was characterized by a provider-centric approach with information silos, to a new model that is focused on patient-centric treatment personalization with high data accessibility and utilization.
Read the full International Comparative Legal Guide.
On February 27, 2024, Turkish Pharmaceuticals and Medical Devices Authority has revised the Guideline on Good Distribution Practice (GDP) Audits, mandating that pharmaceutical businesses with permits undergo inspections to ensure compliance with GDP standards. Identified deficiencies must be remedied within a specified period, with evidence submitted to Authority. Moreover, routine controls by Provincial/District Health Directorates will document deficiencies, requiring businesses to address them within 15 days and submit proof of compliance to Authority.
The Regulation on the Importation of Medical Diagnostic Kits was repealed according to an announcement by the Turkish Ministry of Trade. This regulation, which previously governed the importation procedures and standards for medical diagnostic kits, was officially repealed on May 15, 2024, signifying a change in the regulatory approach to these medical devices.
Publication
In 2018, the Republic of Seychelles launched the first-ever “blue bond”, with the support of the World Bank Group and the Global Environment Facility.
Publication
On 8 May 2025, the Court of Justice of the European Union (the CJEU) delivered its ruling in case C-581/23 (the Ruling), providing guidance on one of the conditions for an exclusive distribution agreement to benefit from the block exemption under Article 4(b)(i) of the 2010 Vertical Block Exemption Regulation (the VBER)1, notably the so-called ‘parallel imposition requirement’.
Publication
Antitrust authorities are increasingly aggressive in pursuing new theories of harm, pushing the boundaries of what amounts to an antitrust violation, and expanding the use of current legislation and regulation to fit a new era of issues.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025